人工肝脏血吸附改善了严重肺炎的老年患者的生存率:一项回顾性队列研究
Richai Chen1, Jiaqian Jin2, Sainan Zhang1
1Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan (Hangzhou) Hospital Affiliated to Shulan International Medical College, Zhejiang Shuren University, Hangzhou, China.
Frontiers in medicine
|July 24, 2025
概括
人工肝血吸附 (ALPA) 疗法显著降低了严重肺炎患者的炎症标志物和死亡率. 这种治疗改善了生存结果,为危急疾病提供了有前途的治疗选择.
科学领域:
- 临界护理医学 临界护理医学
- 肺部病理学 肺部病理学
- 生物医学工程 生物医学工程
背景情况:
- 严重的肺炎在重症监护中是一个重大挑战,往往导致全身炎症和高死亡率.
- 细胞因子风暴是一种高炎症反应,在严重肺炎和相关器官功能障碍的发病过程中起着至关重要的作用.
- 探索新的治疗策略以减轻炎症并改善严重肺炎的结果是必不可少的.
研究的目的:
- 为了评估人工肝血吸附 (ALPA) 在被诊断患有严重肺炎的患者的治疗疗效.
- 评估ALPA对炎症标志物的影响和该患者队列的生存结果.
主要方法:
- 一项回顾性研究,涉及151名入住ICU的重症肺炎患者.
- 患者被分为ALPA干预组 (n=56) 和标准治疗对照组 (n=95).
- 收集和分析了临床数据,包括炎症标志物 (WBC,LY%,CRP,PCT,IL-6) 和生存结果.
主要成果:
- 与对照组相比,ALPA组的WBC,CRP,PCT和IL-6治疗后水平明显较低.
- 死亡率在ALPA组 (42.9%) 与对照组 (81.1%) 相比显著较低 (p < 0.001).
- 治疗ALPA与显著改善的生存结果有关 (平均存活时间:218.42天与36.81天对比).
结论:
- 人工肝血吸附 (ALPA) 疗法在临床上有效抑制炎症标志物和减轻严重肺炎中的细胞因子风暴.
- 在重症肺炎患者中,ALPA疗法显著降低死亡率并延长存活时间.
- ALPA代表了一种有前途的治疗干预措施,用于治疗严重的肺炎并改善患者的预后.
更多相关视频
16:19Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
Published on: September 13, 2014
12.8K
09:44Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
10.3K
相关概念视频
01:28Pneumonia IV: Management
451
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
451
01:21Acute Respiratory Failure-II
368
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
368
01:30Pneumonia V: Nursing management and Prevention
2.5K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.5K
01:30Acute Respiratory Failure-III
325
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
325
01:21Acute Respiratory Failure-I
334
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
334
01:29Acute Respiratory Failure-V
209
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
209